Insider · CIK 0001716468

Manning Anthony M.

Reports to the SEC for 3 companies · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001716468

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-29	GLUEMonte Rosa Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$4.16	+$41.6K	10,000
2026-06-29	GLUEMonte Rosa Therapeutics, Inc.S Sale	Director	SSale	−10K sh	$23.11	−$231K	0
2026-06-29	GLUEMonte Rosa Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	2,100
2026-06-11	GLUEMonte Rosa Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25.8K sh	—	—	25,800
2026-05-21	GLUEMonte Rosa Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$4.16	+$41.6K	10,000
2026-05-21	GLUEMonte Rosa Therapeutics, Inc.S Sale	Director	SSale	−10K sh	$18.01	−$180K	0
2026-05-21	GLUEMonte Rosa Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	12,100
2025-06-13	GLUEMonte Rosa Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+30.7K sh	—	—	30,700
2024-07-15	PTNPALATIN TECHNOLOGIES INCA Award	Director	AAward	+12K sh	—	—	36,080
2024-06-12	GLUEMonte Rosa Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+22.1K sh	—	—	22,100
2023-07-25	GLUEMonte Rosa Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+41K sh	—	—	41,000
2023-07-15	PTNPALATIN TECHNOLOGIES INC · Stock Option (Right to Buy)A Award	Director	AAward	+17K sh	—	—	54,280
2023-06-20	PTNPALATIN TECHNOLOGIES INCA Award	Director	AAward	+10K sh	—	—	36,693
2023-06-20	PTNPALATIN TECHNOLOGIES INC · Stock Option (Right to Buy)A Award	Director	AAward	+16K sh	—	—	16,000
2022-06-22	PTNPALATIN TECHNOLOGIES INCA Award	Director	AAward	+73K sh	—	—	693,667
2022-06-22	PTNPALATIN TECHNOLOGIES INC · Stock Option (Right to Buy)A Award	Director	AAward	+128K sh	—	—	128,000
2021-06-22	PTNPALATIN TECHNOLOGIES INCA Award	Director	AAward	+77K sh	—	—	461,666
2020-10-01	MOMENTA PHARMACEUTICALS INCD Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−12.8K sh	—	—	0
2020-10-01	MOMENTA PHARMACEUTICALS INCRestricted Stock UnitsD Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−45K sh	—	—	0
2020-10-01	MOMENTA PHARMACEUTICALS INCRestricted Stock UnitsD Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−1,500 sh	—	—	0
2020-10-01	MOMENTA PHARMACEUTICALS INCRestricted Stock UnitsD Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−31.5K sh	—	—	0
2020-10-01	MOMENTA PHARMACEUTICALS INCRestricted Stock UnitsD Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−45K sh	—	—	0
2020-10-01	MOMENTA PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−13.3K sh	—	—	0
2020-10-01	MOMENTA PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−20.1K sh	—	—	0
2020-10-01	MOMENTA PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−3,622 sh	—	—	0
2020-10-01	MOMENTA PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−5,841 sh	—	—	0
2020-10-01	MOMENTA PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−73 sh	—	—	0
2020-10-01	MOMENTA PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−3,751 sh	—	—	0
2020-10-01	MOMENTA PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−1,499 sh	—	—	0
2020-10-01	MOMENTA PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−3,242 sh	—	—	0
2020-10-01	MOMENTA PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−52.8K sh	—	—	0
2020-10-01	MOMENTA PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−86.4K sh	—	—	0
2020-08-13	MOMENTA PHARMACEUTICALS INCS Sale	Chief Scientific Officer	SSale	−40 sh	$29.34	−$1,173.6	13,141
2020-08-13	MOMENTA PHARMACEUTICALS INCS Sale	Chief Scientific Officer	SSale	−363 sh	$29.31	−$10.6K	12,778
2020-08-10	MOMENTA PHARMACEUTICALS INCS Sale	Chief Scientific Officer	SSale	−347 sh	$32.36	−$11.2K	13,181
2020-08-07	MOMENTA PHARMACEUTICALS INCM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+750 sh	—	—	13,528
2020-08-07	MOMENTA PHARMACEUTICALS INCRestricted Stock UnitsM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−750 sh	—	—	1,500
2020-07-21	MOMENTA PHARMACEUTICALS INCS Sale	Chief Scientific Officer	SSale	−194 sh	$34.67	−$6,725.98	14,523
2020-07-21	MOMENTA PHARMACEUTICALS INCS Sale	Chief Scientific Officer	SSale	−1,745 sh	$34.69	−$60.5K	12,778
2020-07-20	MOMENTA PHARMACEUTICALS INCM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+33.1K sh	$12.76	+$423K	65,816
2020-07-20	MOMENTA PHARMACEUTICALS INCS Sale	Chief Scientific Officer	SSale	−1,561 sh	$33.95	−$53K	64,255
2020-07-20	MOMENTA PHARMACEUTICALS INCS Sale	Chief Scientific Officer	SSale	−49.5K sh	$33.91	−$1.68M	14,717
2020-07-20	MOMENTA PHARMACEUTICALS INCStock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−33.1K sh	—	—	52,793
2020-07-17	MOMENTA PHARMACEUTICALS INCM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+3,500 sh	—	—	32,691
2020-07-17	MOMENTA PHARMACEUTICALS INCRestricted Stock UnitsM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−3,500 sh	—	—	31,500
2020-06-30	MOMENTA PHARMACEUTICALS INCS Sale	Chief Scientific Officer	SSale	−6,811 sh	$35.10	−$239K	29,191
2020-06-29	MOMENTA PHARMACEUTICALS INCA Award	Chief Scientific Officer	AAward	+15K sh	—	—	36,002
2020-06-29	MOMENTA PHARMACEUTICALS INCRestricted Stock UnitsA Award	Chief Scientific Officer	AAward	+15K sh	—	—	45,000
2020-06-22	PTNPALATIN TECHNOLOGIES INC · Stock Option (Right to Buy)A Award	Director	AAward	+128K sh	—	—	128,000
2020-06-16	PTNPALATIN TECHNOLOGIES INCA Award	Director	AAward	+73K sh	—	—	224,583

Recent filings

Accepted (ET)
Jun 304
Manning Anthony M.0001193125-26-290484
SEC(opens sec.gov)
Jun 124
Manning Anthony M.0001193125-26-269354
SEC(opens sec.gov)
May 224
Manning Anthony M.0001193125-26-236840
SEC(opens sec.gov)
Jun 164
Manning Anthony M.0000950170-25-086703
SEC(opens sec.gov)
Jul 164
Manning Anthony M.0001654954-24-008999
SEC(opens sec.gov)
Jun 134
Manning Anthony M.0000950170-24-073062
SEC(opens sec.gov)
Jul 264
Manning Anthony M.0001209191-23-043408
SEC(opens sec.gov)
Jun 224
Manning Anthony M.0001654954-23-008310
SEC(opens sec.gov)
Jun 244
Manning Anthony M.0001654954-22-008782
SEC(opens sec.gov)
Jun 244
Manning Anthony M.0001654954-21-007255
SEC(opens sec.gov)
Oct 14
Manning Anthony M.0001179110-20-010057
SEC(opens sec.gov)

Companies

Address

MONTE ROSA THERAPEUTICS, INC. 321 HARRISON AVENUE, SUITE 900

BOSTON, MA, 02118